CYTK FY 2019 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M-14.7% YoY

Gross Profit

-$59M-220.5% margin

Operating Income

-$99M-368.0% margin

Net Income

-$122M-452.9% margin

EPS (Diluted)

$-2.59

Cash Flow

Operating Cash Flow

-$91M

Free Cash Flow

-$94M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$290M

Total Liabilities

$301M

Stockholders' Equity

-$11M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$32M	-14.7%
Gross Profit	-$59M	-$58M	-2.8%
Operating Income	-$99M	-$89M	-11.2%
Net Income	-$122M	-$106M	-14.5%